3-5
2026
影响因子区间
242天
平台估算
18%
2025
中国作者发文占比
40000000 IRR;600 USD
收费
期刊简介:Clinical Drug Investigation provides rapid publication of original research covering all phases of clinical drug development and therapeutic use of drugs. The Journal includes:-Clinical trials, outcomes research, clinical pharmacoeconomic studies and pharmacoepidemiology studies with a strong link to optimum prescribing practice for a drug or group of drugs.-Clinical pharmacodynamic and clinical pharmacokinetic studies with a strong link to clinical practice.-Pharmacodynamic and pharmacokinetic studies in healthy volunteers in which significant implications for clinical prescribing are discussed.-Studies focusing on the application of drug delivery technology in healthcare.-Short communications and case study reports that meet the above criteria will also be considered.Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Clinical Drug Investigation may be accompanied by plain language summaries to assist readers who have some knowledge, but non in-depth expertise in, the area to understand important medical advances.
【译文】临床药物研究期刊提供关于临床药物开发所有阶段和药物治疗使用的原创研究快速发表。该期刊包括:与药物或药物组的最佳处方实践有紧密联系的临床试验、结果研究、临床药效经济学研究和药源流行病学研究。-与临床实践有紧密联系的药效动力学和药代动力学研究。-在健康志愿者中进行的药效动力学和药代动力学研究,其中讨论了对临床处方的重大影响。-专注于药物递送技术在医疗保健中的应用的研究。-符合上述标准的简报和案例研究报告也将被考虑。文章可以附带额外的数字功能(包括动画摘要、视频摘要、幻灯片、音频幻灯片、教学视频、信息图表、播客和动画),这些功能旨在增加期刊内容的可见性、读者数量和教育价值。此外,Clinical Drug Investigation 发表的文章可能还附有通俗易懂的摘要,以帮助那些对该领域有一定了解但非深入专家的读者理解重要的医学进展。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q2 | 暂无 |
| 影响因子区间 | 3-5 | 暂无 |